Suppr超能文献

肝细胞癌:一种罕见的眼眶转移瘤。

Hepatocellular Carcinoma: An Uncommon Metastasis in the Orbit.

作者信息

Protopapa Maria-Nikoletta, Lagadinou Maria, Papagiannis Theodoros, Gogos Charalambos A, Solomou Elena E

机构信息

University of Patras Medical School, Rion 26500, Greece.

出版信息

Case Rep Oncol Med. 2020 Feb 26;2020:7526042. doi: 10.1155/2020/7526042. eCollection 2020.

Abstract

Hepatocellular carcinoma (HCC) represents the most common type of primary cancer of the liver and is associated with poor prognosis. It is the most common cause of death in cirrhotic patients and in different studies was shown as the third most common cause of cancer-related deaths worldwide. Each year, approximately half a million people are diagnosed with HCC. In recent decades, the prognosis of patients with HCC has improved because more cases are diagnosed and treated at early stages; high-risk patients (i.e., with chronic HBV or HCV infection) are followed more often for the possibility of HCC, and novel treatment options such as locoregional therapy are used with better overall results. The extrahepatic metastases represent a poor prognostic factor. The most common sites of metastasis in advanced hepatocellular carcinoma are the lung (44%), portal vein (35%), and portal lymph nodes (27%). Also, intra-abdominal lymph nodes and bones are common sites. Orbital metastases rarely occur, representing the 3-7% of orbital masses. These metastases are usually found in advanced tumor stages. The mechanism of metastasis to the orbit is difficult to determine. A hematogenous route, as for other primary neoplasms of the abdomen, may be suspected. Tumor cells may circulate through the vena cava, beyond the pulmonary filter to the heart, and finally be distributed to the orbital region through the arterial systemic circulation. We describe herein a case of an adult male with liver cirrhosis due to alcohol abuse who presented with concomitant diagnosis of HCC and orbit metastasis.

摘要

肝细胞癌(HCC)是最常见的原发性肝癌类型,预后较差。它是肝硬化患者最常见的死亡原因,在不同研究中被列为全球癌症相关死亡的第三大常见原因。每年约有50万人被诊断为HCC。近几十年来,HCC患者的预后有所改善,因为更多病例在早期被诊断和治疗;高危患者(即慢性HBV或HCV感染患者)因有患HCC的可能性而接受更频繁的随访,并且诸如局部区域治疗等新的治疗选择取得了更好的总体效果。肝外转移是一个不良预后因素。晚期肝细胞癌最常见的转移部位是肺(44%)、门静脉(35%)和门静脉淋巴结(27%)。此外,腹腔内淋巴结和骨骼也是常见部位。眼眶转移很少见,占眼眶肿块的3 - 7%。这些转移通常在肿瘤晚期出现。转移至眼眶的机制难以确定。如同腹部其他原发性肿瘤一样,可能怀疑是血行转移途径。肿瘤细胞可能通过腔静脉循环,越过肺循环滤过屏障到达心脏,最终通过动脉系统循环分布至眼眶区域。我们在此描述一例因酗酒导致肝硬化的成年男性病例,该患者同时被诊断为HCC和眼眶转移。

相似文献

1
Hepatocellular Carcinoma: An Uncommon Metastasis in the Orbit.肝细胞癌:一种罕见的眼眶转移瘤。
Case Rep Oncol Med. 2020 Feb 26;2020:7526042. doi: 10.1155/2020/7526042. eCollection 2020.
6
Intraconal Metastasis Leading to Diagnosis of Hepatocellular Carcinoma.导致肝细胞癌诊断的锥内转移
Middle East J Dig Dis. 2020 Jan;12(1):48-51. doi: 10.15171/mejdd.2020.164.

引用本文的文献

3
Ocular Metastatic Tumor in a Patient With Hepatocellular Carcinoma.一名肝细胞癌患者的眼部转移性肿瘤
Cureus. 2024 Nov 25;16(11):e74435. doi: 10.7759/cureus.74435. eCollection 2024 Nov.
7
New approach for hepatocellular carcinoma treatment.肝细胞癌治疗的新方法。
J Med Life. 2022 Jan;15(1):138-143. doi: 10.25122/jml-2021-0088.

本文引用的文献

9
Orbital metastases: diagnosis and course.眼眶转移瘤:诊断与病程
Br J Ophthalmol. 1997 May;81(5):386-90. doi: 10.1136/bjo.81.5.386.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验